TrialCancer chemotherapy and pharmacology2020

Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin

Cheryl S W Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.